PBYI — Puma Biotechnology Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapSuper Stock

Annual balance sheet for Puma Biotechnology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	93.4	82.1	81.1	95.9	101
Net Total Accounts Receivable
Net Total Receivables	28.9	32.5	42.3	47.8	32
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	146	140	134	156	148
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	18.9	15.8	12.5	8.65	5.09
Net Intangible Assets
Other Long Term Assets
Total Assets	244	227	222	231	213
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	114	110	77.5	99.4	96.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	250	229	200	177	121
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-5.95	-2.45	21.6	53.4	92.1
Total Liabilities & Shareholders' Equity	244	227	222	231	213
Total Common Shares Outstanding